Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 30

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 30
---
 •NorthView Acquisition Corporation, a Delaware corporation, which we refer to as “ NorthView,” “ we,” “ us,” or “ our,” is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar Business Combination with one or more businesses. •On December22, 2021, we consummated the IPO of 18,975,000 units at a price of $10.00 per unit (including 2,475,000 units from the full exercise of the underwriters’ over -allotmentoption), generating gross proceeds of $189,750,000. Simultaneously with the closing of the IPO, we consummated the sale of 7,347,500 private placement warrants to the Sponsor at a price of $1.00 per warrant, generating gross proceeds of $7,347,500. Subsequently, the units were separated on January21, 2022, resulting in NorthView’s shares of common stock, its warrants and its rights trading separately. •The NorthView Common Stock was originally sold in the IPO as a component of the NorthView units for $10.00 per unit. The NorthView units consisted of one share of NorthView Common Stock, one right and one -halfof one NorthView warrant. Each right entitles the holder thereof to receive one -tenth(1/10) of one share of common stock upon the consummation of an initial business combination and each warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment. As of [•], the record date, the closing price of the NorthView Common Stock, the NorthView Rights, and the NorthView Warrants were $[•], $[•] and $[•] per security, respectively. •Following the IPO, including the exercise of the over -allotmentoption and the sale of the private placement warrants, a total of $191,647,500 was deposited into a U.S. -basedtrust account with Continental Stock Transfer & Trust Company, acting as trustee. Except as described in the prospectus for the IPO, these proceeds will not be released until the earlier of the completion of an initial Business Combination and NorthView’s redemption of 100% of the outstanding public shares upon its failure to consummate a Business Combination within the completion window. •In connection with a special meeting of NorthView stockholders, held